Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Heerlein, K.
- De Giorgi, S.
- Degraeve, G.
- Frodl, T.
- Hagedoorn, W.
- Oliveira-Maia, A. J.
- Otte, C.
- Perez Sola, V
- Rathod, S.
- Rosso, G.
- Vita, A.
- Morrens, J.
- Rive, B.
- Mulhern Haughey S
- Kambarov, Y.
- Young, A. H.
Grupos
Abstract
Treatment resistant depression (TRD) is diagnosed when patients experiencing a major depressive episode fail to respond to =2 treatments. Along with substantial indirect costs, patients with TRD have higher healthcare resource utilization (HCRU) than other patients with depression. However, research on the economic impact of this HCRU, and differences according to response to treatment, is lacking.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0165-0327, 1573-2517
- Tipo:
- Article
- Páginas:
- 442-450
- PubMed:
- 34742998
- Factor de Impacto:
- 1,791 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF AFFECTIVE DISORDERS ELSEVIER
Citas Recibidas en Web of Science: 35
Documentos
- No hay documentos
Filiaciones
Keywords
- Healthcare resource utilization, Major depressive disorder, Observational study, Real-world evidence, Treatment resistant depression
Portal de investigación